Press Release – New York, NY – June 16, 2026 – Sichenzia Ross Ference Carmel LLP announced that it represented ThinkEquity as the sole placement agent for the recently priced $2.5 million best-efforts offering of CEL-SCI Corporation (NYSE American: CVM), a clinical stage cancer immunotherapy company.
The SRFC team was led by partners Ross Carmel and Avital Perlman, with associates Benasz Hansotia and Jacob Horowitz.